Schedule 13G ownership disclosure

Horizon Pharma plc

Security class unavailable

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000891092-20-000551
Form type
SC 13G/A
Filer
Horizon Therapeutics Public Ltd Co
CIK
CIK 1492426
Filed
Jan 10, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub